Here are six observations:
1. A minimally invasive procedure, lateral lumbar interbody fusion is designed to yield less blood loss and decrease tissue damage.
2. The procedure’s higher visualization and technological advancements in the market will boost adoption, but the procedure’s costliness as well as risks will hinder growth.
3. Some procedure risks include psoas muscles and neural network injury as well as bone graft fusion complications.
4. Market vendors are increasingly offering preoperative and postoperative care for patients as well, expanding their offerings.
5. North America leads the space, due to technologically advanced products and research and development investments.
6. DePuy Synthes, NuVasive, Stryker, Smith & Nephew, Medtronic, Paradigm Spine and Alphatec Spine dominate the market.
More articles on MIS:
Life Spine receives approval to conduct study on open vs. minimally invasive posterior lumbar spine surgery: 5 insights
Houston Methodist Hospital installs Mazor X: 4 notes
Minimally invasive interbody devices — 4 highlights of market report
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.